AVERROES PHARMA
Une procédure de faillite est ouverte pour AVERROES PHARMA selon les publications au Moniteur belge. Les comptes annuels de 2020 montrent des capitaux propres de €999 et un résultat net de €-19k.
| Capitaux propres | €999 |
| Résultat net | €-19k |
| Active | 6 ans |
| Sites | 1 |
Profil fragile — attention surtout à santé.
Faillite ouverte
Une procédure de faillite est déjà en cours — un score de probabilité n'a plus de sens. Consultez la chronologie d'insolvabilité pour l'état de la procédure.
Le détail complet du score, son historique par exercice et la limite de crédit indicative se débloquent à partir de Starter.
Voir les plans →| Exercice | 2020 |
|---|---|
| Chiffre d'affaires | — |
| EBITDA | — |
| Résultat net | €-19k |
| Cash-flow | — |
| Frais de personnel | — |
| Impôts sur le résultat | — |
| Dividendes | — |
| Total actif | €8k |
| Capitaux propres | €999 |
| Dettes | €7k |
| dont ≤ 1 an | €6k |
| dont > 1 an | — |
| Fonds de roulement | €249 |
| Employés (ETP) | — |
| 2020 | |
|---|---|
| Current ratio | 1,04 |
| Quick ratio | 1,04 |
| Ratio fonds de roulement | 3,0% |
| Solvabilité | 12,0% |
| Debt / equity | — |
| Endettement à long terme | — |
| Interest coverage | — |
| Rentabilité brute | — |
| Rentabilité nette | — |
| ROA | -228,1% |
| ROE | -1901,7% |
| Marge EBITDA | — |
| Crédit clients (DSO) | — |
| Crédit fournisseurs (DPO) | — |
| Rotation des stocks | — |
| Jours de stock (DSI) | — |
| Poste | Code | 2020 |
|---|---|---|
| Bilan — Actif | ||
| TOTAL DE L'ACTIF | 20/58 | €8k |
| Actifs immobilisés | 21/28 | €2k |
| Immobilisations financières | 28 | €2k |
| Actifs circulants | 29/58 | €7k |
| Créances à un an au plus | 40/41 | €4k |
| Valeurs disponibles | 54/58 | €2k |
| Bilan — Passif | ||
| TOTAL DU PASSIF | 10/49 | €8k |
| Capitaux propres | 10/15 | €999 |
| Bénéfice (perte) reporté(e) | 14 | €-19k |
| Dettes | 17/49 | €7k |
| Dettes à un an au plus | 42/48 | €6k |
| Dettes commerciales à un an au plus | 44 | €4k |
| Compte de résultats | ||
| Marge brute d'exploitation | 9900 | €-19k |
| Résultat d'exploitation | 9901 | €-19k |
| Charges financières | 65 | €9 |
| Résultat avant impôts | 9903 | €-19k |
| Résultat de l'exercice | 9904 | €-19k |
| Résultat à affecter | 9905 | €-19k |
| Rôle | Nom | Période | Source |
|---|---|---|---|
| Curateur | Dirk DE MAESENEER PEGASUSLAAN 5, 1831 DIEGEM- |
04-02-2025 → auj. | Moniteur belge |
| NACE primaire | Commerce de détail(47730) |
| Forme juridique | SRL(610) |
| Date de constitution | 06-12-2019 |
| Status | Actif |
| Code postal | 1080 |
| Premier signal MB | 10-02-2025 |
| Dernier signal MB | 10-02-2025 |
Parcelles liées à cette entreprise via ses adresses BCE (siège, unités d'établissement, succursales), croisées avec le plan parcellaire cadastral. Ceci montre où l'entreprise est active — pas un registre de propriété.
| Parcelle (capakey) | Région | Superficie | Bâtiments | Hauteur / ét. |
|---|---|---|---|---|
| 21012A0078/00G006 | Bruxelles | 134 m² | 1 · 50 m² | 23,2 m · 7 ét. |
| 21572B0012/00S005 | Bruxelles | 118 m² | 1 · 73 m² | 14,9 m · 4 ét. |
Une seule chronologie de tout ce qui est arrivé à cette entreprise — publications, événements d'insolvabilité et de cycle de vie, changements administratifs et comptes annuels déposés.
19-02-2025 1 administrateur nommé, 1 démissionnaire
- KIKOTA MASIKO — Bestuurder
- Prospère NKANGA EHANGA — Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": "59.02.02 485.29",
"name": "KIKOTA MASIKO",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2025-02-12",
"evidence_quote": "Nomination au poste de l\u0027administrateur \u00E0 l\u0027unanimit\u00E9, monsieur KIKOTA MASIKO inscrit au registre national num\u00E9ro 59.02.02 485.29 d\u00E8s ce jour, il pourra remplir toutes les responsabilit\u00E9s qui lui sont confi\u00E9es.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Prosp\u00E8re NKANGA EHANGA",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "D\u00E9mission de Prosp\u00E8re NKANGA EHANGA au poste d\u0027administrateur.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "sole_shareholder_declaration",
"role": null,
"person": {
"rrn": null,
"name": "KIKOTA MASIKO",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Monsieur KIKOTA MASIKO d\u00E9tient les 100% du capital de l\u0027entreprise.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2025-02-19",
"filing_date": null,
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2024-12-01",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0738.813.960",
"name_full": "AVERROES PHARMA",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}20-11-2024 Toutes les parts sont désormais réunies entre les mains d'un seul actionnaire
Détails techniques
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_transfer",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": "84010841549",
"kind": "person",
"name": "Prosp\u00E8re NKANGA EHANGA",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
}
],
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_transfer",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": "84010841549",
"kind": "person",
"name": "Prosp\u00E8re NKANGA EHANGA",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
}
],
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-11-20",
"filing_date": "2024-11-08",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2024-07-01",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": "2024-07-01"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0738.813.960",
"name_full": "AVERROES PHARMA",
"legal_form": "SRL",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"shareholders_after": [
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Prosp\u00E8re NKANGA EHANGA",
"role": "aandeelhouder",
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "AISSAOUI ATIF",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "AISSAOUI OUSSAMA",
"role": null,
"n_shares": null,
"share_class": null
}
],
"share_classes_after": []
}20-11-2024 1 administrateur nommé, 2 démissionnaires
- Prospère NKANGA EHANGA — Bestuurder
- AISSAOUI ATIF — Bestuurder
- AISSAOUI OUSSAMA — Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": "84 01 08 415 49",
"name": "Prosp\u00E8re NKANGA EHANGA",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "confirmation",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2024-11-08",
"evidence_quote": "Nomination au poste de l\u0027administrateur \u00E0 l\u0027unanimit\u00E9, monsieur Prosp\u00E8re NKANGA EHANGA inscrite au registre national num\u00E9ro 84 01 08 415 49 d\u00E8s ce jour, il pourra remplir toutes les responsabilit\u00E9s qui lui sont confi\u00E9es.",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "AISSAOUI ATIF",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "D\u00E9mission d\u0027AISSAOUI ATIF au poste d\u0027administrateur.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "AISSAOUI OUSSAMA",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "D\u00E9mission \u00E9galement d\u0027AISSAOUI OUSSAMA au poste d\u0027administrateur.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "board_snapshot",
"role": null,
"person": {
"rrn": null,
"name": "NKANGA EHANGA PROSPERE",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Administrateur: NKANGA EHANGA PROSPERE",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2024-11-20",
"filing_date": "2024-11-08",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2024-07-01",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0738.813.960",
"name_full": "AVERROES PHARMA",
"legal_form": "SRL",
"_kbo_filled_from_list": true
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}20-11-2024 Transfert du siège social de Saint-Josse-ten-Noode à Molenbeek Saint-Jean
- 18 RUE MERINOS-1210 BRUXELLES → rue de l'intendant 184-1080 Molenbeek Saint-Jean
Détails techniques
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "rue de l\u0027intendant 184-1080 Molenbeek Saint-Jean",
"city": "Molenbeek Saint-Jean",
"region": "brussels_hoofdstedelijk_gewest",
"street": "rue de l\u0027intendant",
"country": "BE",
"postcode": "1080",
"box_number": null,
"street_number": "184",
"locality_suffix": null
},
"old_address": {
"raw": "18 RUE MERINOS-1210 BRUXELLES",
"city": "Saint-Josse-ten-Noode",
"region": "brussels_hoofdstedelijk_gewest",
"street": "Rue M\u00E9rinos",
"country": "BE",
"postcode": "1210",
"box_number": null,
"street_number": "18",
"locality_suffix": null
},
"effective_date": null,
"evidence_quote": "",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "immediate",
"statutaire_vs_werkelijke": null,
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2024-11-20",
"filing_date": "2024-11-08",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale",
"date": "2024-07-01",
"unanimous": true
},
"subject_company": {
"kbo": "0738.813.960",
"name_full": "AVERROES PHARMA",
"legal_form": "SRL",
"_kbo_filled_from_list": true
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": []
}19-04-2023 1 administrateur nommé, 1 démissionnaire
- AISSAOUI Atif — Bestuurder
- KHAYAT SRITAH Mohammed — Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "KHAYAT SRITAH Mohammed",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "D\u00E9mission de monsieur KHAYAT SRITAH Mohammed de son poste d\u0027administrateur et lui donne quitus, et ce \u00E0 partir de ce jour qui accepte.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "AISSAOUI Atif",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "Nomination de monsieur AISSAOUI Atif comme nouvel administrateur (\u00E0 titre gratuit) de ladite soci\u00E9t\u00E9, et ce \u00E0 partir de ce jour qui accepte.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": null,
"filing_date": null,
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2022-12-19",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0738.813.960",
"name_full": "AVERROES PHARMA SRL",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}Générez une note structurée et factuelle à partir de tous les signaux de ce dossier : risque, santé financière, structure de propriété, mandats et comparaison sectorielle.
| Dénomination légaleFR | AVERROES PHARMA |